Literature DB >> 7469554

Coagulation changes in elective surgery and trauma.

A E Seyfer, A V Seaber, F A Dombrose, J R Urbaniak.   

Abstract

Although antithrombin-3 (AT-3), a naturally-occurring inhibitor of thrombin, has been associated with a variety of thrombotic disorders, it has been studied in surgery and trauma. Three groups of patients were studied: Group I (20 patients) who underwent elective surgery; Group II (ten patients) who sustained moderate trauma: Group III (ten patients) who sustained severe trauma. Hypercoagulability panels were run preoperatively, intraoperatively, and postoperatively. Nine units of banked blood were also tested. The coagulation pattern changed during the stress, becoming hypercoagulable in proportion to the stress endured by the patient. In the severe trauma group, AT-3 fell significantly (p less than or equal to 0.002) in all patients, indicating extreme hypercoagulability. Three of these patients sustained thrombosis and loss of the involved extremity. The banked blood was found to be hypercoagulable. It appears that patients who sustain severe trauma, have multiple transfusions, and major operative procedures are at increased risk of developing postoperative thrombotic complications, including loss of limb.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7469554      PMCID: PMC1345044          DOI: 10.1097/00000658-198102000-00015

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  13 in total

1.  Inherited antithrombin-III deficiency causing mesenteric venous infarction: a new clinical entity.

Authors:  J C Gruenberg; R C Smallridge; R D Rosenberg
Journal:  Ann Surg       Date:  1975-06       Impact factor: 12.969

2.  The effects of operative stress on the coagulation profile.

Authors:  G J Collins; J A Barber; R Zajtchuk; D Vanek; L A Malogne
Journal:  Am J Surg       Date:  1977-05       Impact factor: 2.565

3.  Hypercoagulability in mesenteric venous occlusion: report of two cases.

Authors:  G J Collins; T F Zuck; R Zajtchuk; R L Heymann
Journal:  Am J Surg       Date:  1976-09       Impact factor: 2.565

4.  Postoperative antithrombin. 3.

Authors:  M B Donati; K Vandenberghe; A Molla; M De Roo; M Verstraete
Journal:  Lancet       Date:  1973-03-31       Impact factor: 79.321

5.  Postoperative antithrombin-3 concentration.

Authors:  N Stathakis; A G Papayannis; C D Gardikas
Journal:  Lancet       Date:  1973-02-24       Impact factor: 79.321

6.  Oral contraceptives and low antithrombin-3 concentration.

Authors:  M K Fagerhol; U Abildgaard; P Bergsjo; J H Jacobsen
Journal:  Lancet       Date:  1970-05-30       Impact factor: 79.321

7.  Major operations, hemostatic parameters and venous thrombosis.

Authors:  E Korvald; U Abildgaard; M K Fagerhol
Journal:  Thromb Res       Date:  1974-01       Impact factor: 3.944

8.  The pathology of intracranial venous thrombosis in oral contraception.

Authors:  A A Poltera
Journal:  J Pathol       Date:  1972-04       Impact factor: 7.996

9.  Antithrombin 3 and diseases.

Authors:  E Von Kaulla; K N Von Kaulla
Journal:  Am J Clin Pathol       Date:  1967-07       Impact factor: 2.493

10.  Hypercoagulability in patients with peripheral vascular disease.

Authors:  G J Collins; R L Heymann; R Zajtchuk
Journal:  Am J Surg       Date:  1975-07       Impact factor: 2.565

View more
  14 in total

1.  Antithrombin III and early prognosis in polytraumatized patients: a pilot study.

Authors:  E Nedorn; F Wosegien; G Kemmler
Journal:  Klin Wochenschr       Date:  1991-10-31

Review 2.  Postoperative changes in hemostasis analyzed by the serial determination of fibrinopeptides and D-dimer.

Authors:  J Kang; J Kambayashi; M Sakon; T Tsujinaka; T Mori
Journal:  Jpn J Surg       Date:  1989-05

Review 3.  Management of coagulopathy in the setting of acute neurosurgical disease and injury.

Authors:  Marlon Mathews; Richard Newman; E Thomas Chappell
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

4.  A Nanoscale Tool for Photoacoustic-Based Measurements of Clotting Time and Therapeutic Drug Monitoring of Heparin.

Authors:  Junxin Wang; Fang Chen; Santiago J Arconada-Alvarez; James Hartanto; Li-Peng Yap; Ryan Park; Fang Wang; Ivetta Vorobyova; Grant Dagliyan; Peter S Conti; Jesse V Jokerst
Journal:  Nano Lett       Date:  2016-09-28       Impact factor: 11.189

5.  Interleukin-6 and coagulation-fibrinolysis fluctuations after laparoscopic and conventional cholecystectomy.

Authors:  G Vander Velpen; F Penninckx; R Kerremans; J Van Damme; J Arnout
Journal:  Surg Endosc       Date:  1994-10       Impact factor: 4.584

6.  Coagulation studies in patients with orthopedic trauma.

Authors:  Kanchana Rangarajan; Arulselvi Subramanian; Jatin S Gandhi; Namit Saraf; Vijay Sharma; Kamran Farooque
Journal:  J Emerg Trauma Shock       Date:  2010-01

7.  Discontinuation of warfarin is unnecessary in total knee arthroplasty.

Authors:  David A Rhodes; Erik P Severson; Jeffrey T Hodrick; Harold K Dunn; Aaron A Hofmann
Journal:  Clin Orthop Relat Res       Date:  2010-01       Impact factor: 4.176

Review 8.  Prevention of venous thromboembolism following orthopaedic surgery: clinical potential of direct thrombin inhibitors.

Authors:  Bengt I Eriksson; Ola E Dahl
Journal:  Drugs       Date:  2004       Impact factor: 9.546

9.  Results of adjusted-dose heparin for thromboembolism prophylaxis in knee replacement compared to those found for its use in hip fracture surgery and elective hip replacement.

Authors:  David Yen; William Weiss
Journal:  Iowa Orthop J       Date:  2007

10.  Influence of suction-assisted lipectomy on coagulation.

Authors:  K A Smith; R H Levine
Journal:  Aesthetic Plast Surg       Date:  1992       Impact factor: 2.326

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.